Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × trilaciclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 7 Triple Negative Breast Neoplasms 6 Breast Neoplasms 6 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Pathologic Complete Response 1 Osteosarcoma 1 Neutropenia 1 Neoplasms 1 NSCLC 1 Myelosuppression 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced Squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 203 Radiotherapy 150 Cetuximab 115 pembrolizumab 96 Fluorouracil 78 Docetaxel 76 Paclitaxel 66 Carboplatin 66 Radiotherapy, Intensity-Modulated 59 Nivolumab 33 Radiation 28 Drug Therapy 26 Gemcitabine 22 Gefitinib 19 Erlotinib Hydrochloride 19 Standard of Care 17 Cyclophosphamide 17 durvalumab 16 Surgical Procedures, Operative 16 Magnetic Resonance Spectroscopy 16 Surveys and Questionnaires 15 Pemetrexed 15 atezolizumab 14 Bevacizumab 14 Low-Level Light Therapy 13 Filgrastim 13 Celecoxib 13 Capecitabine 13 Amifostine 13 Radiosurgery 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06752798 2024-12-31

CCRT，LA-HNSCC

Hunan Cancer Hospital

Phase 2 Recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡